According to Biolase 's latest financial reports the company's current EPS (TTM) is -$467.52. In 2022 the company made an earnings per share (EPS) of -$725.26 a decrease over its 2021 EPS that were of -$472.02.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$436.60 | -39.8% |
2022 | -$725.26 | 53.65% |
2021 | -$472.02 | -81.87% |
2020 | -$2,603 | -25.32% |
2019 | -$3,485 | -24.76% |
2018 | -$4,632 | -26.06% |
2017 | -$6,265 | 4.33% |
2016 | -$6,005 | -14.71% |
2015 | -$7,040 | -26.09% |
2014 | -$9,525 | 35.41% |
2013 | -$7,034 | 244.31% |
2012 | -$2,043 | -38.05% |
2011 | -$3,298 | -64.8% |
2010 | -$9,368 | 347.66% |
2009 | -$2,093 | -71.05% |
2008 | -$7,230 | 22.58% |
2007 | -$5,898 | 55% |
2006 | -$3,805 | -74.03% |
2005 | -$14,649 | -22.22% |
2004 | -$18,835 | -208.79% |
2003 | $17,313 | 1720% |
2002 | $951.25 | -171.43% |
2001 | -$1,332 | -65% |
2000 | -$3,805 | -28.57% |
1999 | -$5,327 | -56.92% |
1998 | -$12,366 | 209.52% |
1997 | -$3,995 | 5% |
1996 | -$3,805 |